Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

University of Miami40 enrolled

Overview

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Enrollment

Conditions

HIV Infections

Interventions

ACCESS InterventionBEHAVIORAL

Participants will receive the ACCESS intervention with funding, consisting of up to 16 hours of practice facilitation per month in person and/or virtually. Practice facilitation is training and support on implementation of routine HIV/HCV screening.

Control GroupBEHAVIORAL

Participants will receive a link to the CDC compendium of evidence-based interventions for HIV prevention.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * SSPs must: 1. be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions; 2. serve at least 300 unique participants per year; 3. not currently offer opt-out HIV/HCV testing; 4. be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics; 5. have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study. Exclusion Criteria: * SSPs must not: 1. currently receive or have received Frontline Communities in the United States (FOCUS) funding; 2. have already implemented opt-out HIV/HCV testing. 3. currently participating in SAIA-SSP-HIV (NCT06025435)

Locations (1)

University of Miami

Miami, Florida, United States

RECRUITING

Outcomes

Primary Outcomes

Number of SSP participants reached

Number of total HIV/HCV tests completed divided by the number of unique individuals seen

Time frame: up to 18 months

Adoption

Proportion of SSPs that have created an HIV/HCV opt-out testing policy

Time frame: up to 6 months

Secondary Outcomes

Number of SSP participants reached after the intervention

Number of total HIV/HCV tests completed divided by the number of unique individuals seen

Time frame: up to 30 months

Central Contacts

Hansel Tookes, MD

CONTACT

3056897030 hetookes@miami.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.